Biological markers in osteoarthritis (Q36835538)

16 August 2017

1 reference

title

Biological markers in osteoarthritis. (English)

1 reference

16 August 2017

1 reference

Jean-Charles Rousseau

series ordinal

1

1 reference

PubMed ID

17538566

16 August 2017

Pierre D Delmas

series ordinal

2

1 reference

16 August 2017

1 June 2007

1 reference

Nature Clinical Practice Rheumatology

16 August 2017

1 reference

16 August 2017

3

1 reference

16 August 2017

346-356

1 reference

16 August 2017

6

1 reference

Cartilage imaging in osteoarthritis

16 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Classification of osteoarthritis biomarkers: a proposed approach.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

The associations of bone mineral density and bone turnover markers with osteoarthritis of the hand and knee in pre- and perimenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

The role of bone metabolism in osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Review: Collagen markers in early arthritic diseases.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Joint fluid carboxy-terminal type II procollagen peptide as a marker of cartilage collagen biosynthesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Evidence for altered synthesis of type II collagen in patients with osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Anabolic and catabolic function of chondrocyte ex vivo is reflected by the metabolic processing of type II collagen

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Collagen type II C-telopeptide fragments as an index of cartilage degradation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

AGEing and osteoarthritis: a different perspective

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Use of the plasma stromelysin (matrix metalloproteinase 3) concentration to predict joint space narrowing in knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Serum cartilage oligomeric matrix protein and clinical signs and symptoms of potential pre-radiographic hip and knee pathology

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with the osteoarthritis-related type II collagen gene COL2A1 mutation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Association of higher levels of serum cartilage oligomeric matrix protein and N-telopeptide crosslinks with the development of radiographic hip osteoarthritis in elderly women

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

C-reactive protein as a biomarker of emergent osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Biological markers for osteoarthritis: an update

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: The Johnston county osteoarthritis project

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Association between spine disc degeneration and type II collagen degradation in postmenopausal women: the OFELY study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Procollagen II C propeptide level in the synovial fluid as a predictor of radiographic progression in early knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

A new marker for osteoarthritis: Cross-sectional and longitudinal approach

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Tissue inhibitor of metalloprotease-1 (TIMP-1) serum level may predict progression of hip osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM).

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Identification of an urinary metabolite profile associated with osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Recent advances in the genetic investigation of osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Aggrecan core protein of a certain length is protective against hand osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0508

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0508

1 reference

16 August 2017

1 reference

PubMed ID

17538566